This inventor holds 1 USPTO granted patent. Top assignee: Cytochroma Inc.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovations of Andrew Howard Collop
Introduction
Andrew Howard Collop is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various diagnostic applications, including cancer detection and vitamin D metabolic conditions.
Latest Patents
Andrew Howard Collop holds a patent for the invention titled "Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof." This invention relates to a monoclonal antibody for CYP24 and encompasses methods and uses such as Western blot analysis, immunohistochemistry, and protein purification. The patent also addresses diagnostic applications, particularly for cancer and vitamin D metabolic conditions. He has 1 patent to his name.
Career Highlights
Collop is associated with Cytochroma Inc., a company focused on innovative solutions in the field of biotechnology. His work at Cytochroma has allowed him to explore and develop groundbreaking technologies that enhance diagnostic capabilities in healthcare.
Collaborations
One of his notable collaborators is Samuel Suming Chuang. Their partnership has contributed to advancements in the research and application of monoclonal antibodies.
Conclusion
Andrew Howard Collop's contributions to biotechnology, particularly through his patent on CYP24 monoclonal antibodies, highlight his role as an innovator in the field. His work continues to influence diagnostic methods and improve healthcare outcomes.